The pharmacogenetics of tacrolimus and its implications for personalized therapy in kidney transplant recipients-Reference-Cited by-同舟云学术

The pharmacogenetics of tacrolimus and its implications for personalized therapy in kidney transplant recipients

Published:2020-06-19 Issue:5 Volume:5 Page:313-316
ISSN:2380-8993
Container-title:Expert Review of Precision Medicine and Drug Development
language:en
Short-container-title:Expert Review of Precision Medicine and Drug Development

Author:

Francke Marith I.¹²,de Winter Brenda C.M.³,Elens Laure⁴,Lloberas Nuria⁵,Hesselink Dennis A.¹²

Affiliation:

1. Department of Internal Medicine, Division of Nephrology and Transplantation, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands

2. Rotterdam Transplant Group, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands

3. Department of Hospital Pharmacy, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands

4. Louvain Drug Research Institute, Université Catholique De Louvain, Louvain, Belgium

5. Department of Nephrology, IDIBELL, Hospital Universitari Di Bellvitge, University of Barcelona, Barcelona, Spain

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/23808993.2020.1776107

Reference48 articles.

1. Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report

2. FK 506 FOR LIVER, KIDNEY, AND PANCREAS TRANSPLANTATION

3. A population pharmacokinetic model to predict the individual starting dose of tacrolimus in adult renal transplant recipients

4. Intra-patient variability in tacrolimus exposure: Causes, consequences for clinical management

5. Overweight Kidney Transplant Recipients Are at Risk of Being Overdosed Following Standard Bodyweight-Based Tacrolimus Starting Dose

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A descriptive study of the single-nucleotide polymorphisms known to affect the Tacrolimus trough concentration per dose, among a population of kidney failure patients in a tertiary hospital in Ghana;BMC Research Notes;2024-07-29

2. A prospective controlled, randomized clinical trial of kidney transplant recipients developed personalized tacrolimus dosing using model-based Bayesian Prediction;Kidney International;2023-10

3. Personalized immunosuppression after kidney transplantation;Nephrology;2022-03-09

4. Towards next-generation personalization of tacrolimus treatment: a review on advanced diagnostic and therapeutic approaches;Pharmacogenomics;2021-11

5. Minimization of Immunosuppressive Therapy Is Associated with Improved Survival of Liver Transplant Patients with Recurrent Hepatocellular Carcinoma;Cancers;2021-03-31